Karyopharm Therapeutics Inc. (KPTI)
MA
Total Compensation for Fiscal Year Ending in 2022: $6,910,015
| Salary | $696,800 |
|---|---|
| Bonus | $200,000 |
| Value of Stock Awards | $2,982,788 |
| Value of Option Awards | $2,562,984 |
| Non-Equity Incentive Plan Compensation | $452,920 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $14,523 |
| Total | $6,910,015 |
Karyopharm Therapeutics Inc. disclosed its CEO pay was
31
times its median employee's pay for the fiscal year ending in 2022.
How Do You Compare?
